doi: 10.1111/j.1365-2265.2009.03575.x 110 LiMChenYLiaoBTangJZhongJLanD
Acknowledgements NEWEST is an acronym for N-acetylcystEine Nebulizer Therapy in COPD Patients With Difficulty of Expectoration to Evaluate Symptom ImprovemenT The Korean Pulmonary Rehabilitation Study Group in The Korean Academy of Tuberculosis and Respiratory Diseases (KATRD) Members Chin Kook Rhee, 1 Seong Yong Lim, 2 Won-Yeon Lee, 3 Ji Ye Jung, 4 Yong Bum Park, 5 Chang Youl Lee, 6 Yong Il Hwang, 7 Jin Woo Song, 8 Won-Il Choi, 9 Kwang Ha Yoo, 10 Ki Uk Kim, 11 Yu-Il Kim, 12 Tae-Hyung Kim, 13 Seong Ju Park, 14 Kyeong-Cheol Shin, 15 Soo-Jung Um, 16 Hyoung Kyu Yoon, 17 Ho Sung Lee, 18 Deog Kyeom Kim, 19 Ah Young Leem 4 1 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St
Their study demonstrated that pre-treatment with this compound significantly improved survival, reduced serum cytokine levels, and mitigated liver and lung injury following LPS challenge ( TABLE 1 Clinical and preclinical investigations of superoxide dismutase (SOD) as a biomarker and therapeutic modulator in sepsis pathophysiology
To translate this potential into optimized clinical practice, several research priorities should be emphasized
